Last A$0.0010 AUD
Change Today 0.00 / 0.00%
Volume 0.0
ACU On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:16 AM 03/21/14 All times are local (Market data is delayed by at least 15 minutes).

acuvax ltd (ACU) Snapshot

Open
--
Previous Close
A$0.0010
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
A$-0.0005
Shares Outstanding
3.9B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACUVAX LTD (ACU)

Related News

No related news articles were found.

acuvax ltd (ACU) Related Businessweek News

No Related Businessweek News Found

acuvax ltd (ACU) Details

Acuvax Limited, through its subsidiaries, primarily researches and develops cancer therapies in Australia. It is also involved in the development of virus and vaccines. The company was formerly known as Avantogen Limited. Acuvax Limited is based in West Perth, Australia.

acuvax ltd (ACU) Top Compensated Officers

Founder, Chief Scientific Officer of Adjuvant...
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Chief Operating Officer and Director Nominee
Total Annual Compensation: --
Company Secretary and Non Executive Director
Total Annual Compensation: --
General Counsel
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

acuvax ltd (ACU) Key Developments

Acuvax Limited, Special/Extraordinary Shareholders Meeting, Jul 30, 2014

Acuvax Limited, Special/Extraordinary Shareholders Meeting, Jul 30, 2014.

Acuvax Ltd. Appoints Alex Bajada as Non Executive Director

Acuvax Ltd. announced the appointment of Alex Bajada as a non executive director of the company. Mr. Bajada has long term experience as both Chairman and director of several ASX listed companies, including the role of Deputy Chair of Advance Healthcare Ltd. Mr. Bajada shortly completes over 20 years as a director and at certain times chairman of WA Super Ltd. As a result Mr. Bajada should be available to commit to assisting in the development of Acuvax Ltd. projects. Mr. Bajada is also a non executive director of private equity fund Hawkesbridge Ltd. and Wesmaem Ltd.

Acuvax Announces Resignation of Anton Uvarov as a Non-Executive Director from the Board

Dr. Anton Uvarov has resigned as a Non-Executive Director from the board of Acuvax.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACU:AU A$0.00 AUD 0.00

ACU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACU.
View Industry Companies
 

Industry Analysis

ACU

Industry Average

Valuation ACU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 732.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 769.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACUVAX LTD, please visit www.acuvax.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.